NAPIGEN Completes $7.85 Million Funding Round to Advance Its Mitochondrial and Chloroplast Gene Editing Technology
July 12, 2022 08:15 ET
|
Napigen, Inc.
WILMINGTON, Del., July 12, 2022 (GLOBE NEWSWIRE) -- NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, completed a $7.85 million seed funding round. ...
Gene Editing Market Is Expected to Reach $7.4 Billion by 2031, Claims AMR
July 11, 2022 06:37 ET
|
Allied Market Research
Portland, OR, July 11, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global gene editing market was estimated at $3.9 billion in 2021, and is anticipated...
Global Cell Therapy Technologies Market (2022 to 2031) - Featuring Thermo Fisher Scientific, Merck, MaxCyte and Lonza Group Among Others
June 24, 2022 05:53 ET
|
Research and Markets
Dublin, June 24, 2022 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Global Market Report 2022, By Product, By Cell Type, By Process, By End User" report has been added to...
Insights on the Genome Editing Global Market to 2027 - Growing Cases of Cancer and Other Genetic Disorders is Driving Growth
June 22, 2022 06:03 ET
|
Research and Markets
Dublin, June 22, 2022 (GLOBE NEWSWIRE) -- The "Genome Editing Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. Genome editing is a method of making...
The Worldwide Epigenetics Industry is Expected to Reach $2.9 Billion by 2028
June 16, 2022 05:43 ET
|
Research and Markets
Dublin, June 16, 2022 (GLOBE NEWSWIRE) -- The "Global Epigenetics Market Size, Share & Industry Trends Analysis Report By Application (Oncology and Non-Oncology), By Product, By End User, By...
Global CRISPR Technology Market Analysis 2022-2026, Featuring Profiles of Thermo Fisher Scientific, CRISPR Therapeutics, GenScript Biotech, Editas Medicine and Intellia Therapeutics
April 19, 2022 04:08 ET
|
Research and Markets
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "CRISPR Technology Global Market Report 2022, By Product Type, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering....
Global Gene Editing Market Analysis 2022-2026, Featuring Profiles of CRISPR, GenScript, Thermo Fisher Scientific, Merck and AstraZeneca
April 19, 2022 04:03 ET
|
Research and Markets
Dublin, April 19, 2022 (GLOBE NEWSWIRE) -- The "Gene Editing Global Market Report 2022, By Technology, By End Users, By Application" report has been added to ResearchAndMarkets.com's offering. The...
Insights on the Artificial Intelligence in Digital Genome Global Market to 2028 - by Offering, Technology, Functionality, Application, End-user, and Region
April 18, 2022 07:48 ET
|
Research and Markets
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence in Digital Genome Market, by Offering, by Technology, by Functionality, by Application, by End User, and by Region - Size,...
Global $14.9 Bn Nucleic Acid Based Gene Therapy Markets, 2015-2020, 2025F, 2030F
April 07, 2022 04:58 ET
|
Research and Markets
Dublin, April 07, 2022 (GLOBE NEWSWIRE) -- The "Nucleic Acid Based Gene Therapy Global Market Opportunities And Strategies To 2030, By Nucleic Acid Technology, Application, End User" report has been...
Cytovia Therapeutics’ Leadership to Present at Upcoming Conferences
March 29, 2022 10:56 ET
|
Cytovia Therapeutics
AVENTURA, Fla. and NATICK, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell...